Axxcess Wealth Management LLC Acquires 2,246 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Axxcess Wealth Management LLC grew its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 201.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,362 shares of the company’s stock after buying an additional 2,246 shares during the quarter. Axxcess Wealth Management LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $228,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in IHE. Truist Financial Corp raised its holdings in iShares U.S. Pharmaceuticals ETF by 1.1% in the 4th quarter. Truist Financial Corp now owns 4,703 shares of the company’s stock valued at $872,000 after acquiring an additional 53 shares during the period. Janney Montgomery Scott LLC raised its holdings in iShares U.S. Pharmaceuticals ETF by 0.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 12,131 shares of the company’s stock valued at $2,249,000 after acquiring an additional 114 shares during the period. Y.D. More Investments Ltd raised its holdings in iShares U.S. Pharmaceuticals ETF by 29.0% in the 4th quarter. Y.D. More Investments Ltd now owns 516 shares of the company’s stock valued at $96,000 after acquiring an additional 116 shares during the period. Private Advisor Group LLC raised its holdings in iShares U.S. Pharmaceuticals ETF by 10.8% in the 4th quarter. Private Advisor Group LLC now owns 1,362 shares of the company’s stock valued at $253,000 after acquiring an additional 133 shares during the period. Finally, National Bank of Canada FI raised its holdings in iShares U.S. Pharmaceuticals ETF by 274.0% in the 4th quarter. National Bank of Canada FI now owns 187 shares of the company’s stock valued at $35,000 after acquiring an additional 137 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Up 0.8 %

Shares of NYSEARCA:IHE opened at $69.15 on Friday. The company’s 50 day moving average price is $66.82 and its two-hundred day moving average price is $66.17. iShares U.S. Pharmaceuticals ETF has a 12-month low of $55.36 and a 12-month high of $69.56. The firm has a market cap of $698.42 million, a PE ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.